Resources and useful links
Q: I’ve experienced SJS/TEN in the past – is it safe to have the COVID vaccine?
A: Based on data from the clinical trials that have been reported so far, there is no evidence that the COVID vaccine leads to SJS/TEN. The MHRA is building up a database of safety information as more people are vaccinated.
Q: Should I have the vaccine?
A: Based on the currently known balance of benefits and risks, it would be important for anyone on the Joint Committee on Vaccination and Immunisation (JCVI) prioritisation list to be vaccinated. Click here to see the list - https://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-30-december-2020
Q: Which of the vaccines would be best for me?
A: Unfortunately we are unable to advise on a particular vaccine that would be most suited to you. The best available information is that all of the vaccines provide protection against serious COVID disease, and at this point in time there is no evidence to suggest that any of the vaccines pose a threat of new or repeat episodes of SJS/TEN.
Q: Where can I find more information?
A: It is vital that information on healthcare and vaccination is obtained from reliable, reputable sources. Click here to read vaccination information that relates to the United Kingdom - https://www.nhs.uk/conditions/coronavirus-covid-19/coronavirus-vaccination/
Apologies that our advice is limited at the moment. The MHRA will continue to build on the existing knowledge and will hopefully be able to provide more tailored advice following the full vaccination programme.
We have provided here a list of useful links related to charities and organisation in the area of drug reaction and others:
COVID-19 Vaccine News from JCVI
The Joint Committee on Vaccination and Immunisation says 1 dose shown to be just as effective as 2 at preventing cancers caused by HPV in adolescents.
An interim statement from the Joint Committee on Vaccination and Immunisation (JCVI) on changes to the childhood immunisation schedule.
The Joint Committee on Vaccination and Immunisation's (JCVI) concluding advice on a one-dose schedule for the human papillomavirus (HPV) immunisation programme.
Latest updates on cases of monkeypox identified by the UK Health Security Agency (UKHSA).
A report covering adverse reactions to approved COVID-19 vaccines
Talks from the SJS Awareness UK Patient & Public Involvement Group Meeting, September 2021